About: RS-102221

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

RS-102221 is a drug developed by Hoffmann–La Roche, which was one of the first compounds discovered that acts as a potent and selective antagonist at the serotonin 5-HT2C receptor, with around 100x selectivity over the closely related 5-HT2A and 5-HT2B receptors. It has anxiolytic effects in animal studies, increases the effectiveness of SSRI antidepressants, and shows a complex interaction with cocaine, increasing some effects but decreasing others, reflecting a role for the 5-HT2C receptor in regulation of the dopamine signalling system in the brain.

Property Value
dbo:abstract
  • RS-102221 is a drug developed by Hoffmann–La Roche, which was one of the first compounds discovered that acts as a potent and selective antagonist at the serotonin 5-HT2C receptor, with around 100x selectivity over the closely related 5-HT2A and 5-HT2B receptors. It has anxiolytic effects in animal studies, increases the effectiveness of SSRI antidepressants, and shows a complex interaction with cocaine, increasing some effects but decreasing others, reflecting a role for the 5-HT2C receptor in regulation of the dopamine signalling system in the brain. (en)
dbo:casNumber
  • 185376-97-0
dbo:chEMBL
  • 88402
dbo:pubchem
  • 3693566
dbo:thumbnail
dbo:wikiPageID
  • 20565643 (xsd:integer)
dbo:wikiPageLength
  • 5932 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1105896125 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 27 (xsd:integer)
dbp:casNumber
  • 185376 (xsd:integer)
dbp:chembl
  • 88402 (xsd:integer)
dbp:chemspiderid
  • 2925610 (xsd:integer)
dbp:f
  • 3 (xsd:integer)
dbp:h
  • 33 (xsd:integer)
dbp:iupacName
  • N-{5-[5-pentanoyl] -2,4-dimethoxyphenyl}-4-benzenesulfonamide (en)
dbp:iupharLigand
  • 187 (xsd:integer)
dbp:n
  • 4 (xsd:integer)
dbp:o
  • 7 (xsd:integer)
dbp:pubchem
  • 3693566 (xsd:integer)
dbp:s
  • 1 (xsd:integer)
dbp:smiles
  • c4ccccc4SNccc2CCCCCNCCC13NCNC1=O (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • HZZZZODVDSHQRG-UHFFFAOYSA-N (en)
dbp:synonyms
  • RS-102,221; 8-[5- (en)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 407718072 (xsd:integer)
dbp:width
  • 250 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • RS-102221 is a drug developed by Hoffmann–La Roche, which was one of the first compounds discovered that acts as a potent and selective antagonist at the serotonin 5-HT2C receptor, with around 100x selectivity over the closely related 5-HT2A and 5-HT2B receptors. It has anxiolytic effects in animal studies, increases the effectiveness of SSRI antidepressants, and shows a complex interaction with cocaine, increasing some effects but decreasing others, reflecting a role for the 5-HT2C receptor in regulation of the dopamine signalling system in the brain. (en)
rdfs:label
  • RS-102221 (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License